FDA Roundup: January 14, 2025

SILVER SPRING, Md., Jan. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

    --  Today, the FDA issued a Request for Information (RFI) on industry
        practices related to poppy seeds. The FDA is interested in better
        understanding the agricultural, industry, manufacturing, and supply
        chain practices currently being used, and whether certain practices
        increase or reduce the presence of opiate alkaloids on poppy seeds.


    --  Today, the FDA's Center for Veterinary Medicine issued a Dear
        Veterinarian letter alerting practitioners to the possibility of burns
        associated with the use of Megadyne grounding pads in animal surgical
        patients.


    --  On Monday, the FDA published the FDA Voices, "Vaccines for COVID-19: A
        Personal Reflection," by Robert M. Califf, MD, Commissioner of Food and
        Drugs. This FDA Voices is Dr. Califf's personal reflection on the status
        of COVID vaccines, which he says constitute one of the most important
        elements of government policy, particularly as it relates to the FDA and
        his term as Commissioner. It is not intended to be an exhaustive
        systematic review or to represent the policies of the current
        administration.


    --  On Monday, the FDA published the blog, "FDA Spearheads Global Efforts on
        Informal Markets and Substandard/Falsified Medical Products." This blog
        is the latest in the "From A Global Perspective" series and discusses
        the FDA's role in leading WHO efforts to address knowledge gaps
        regarding the global distribution of substandard and falsified medical
        products through informal/unregulated markets.
    --  On Friday, the FDA, U.S. Homeland Security Investigations, and U.S.
        Customs and Border Protection announced the seizure of more than 628,000
        unauthorized e-cigarette products from a warehouse in Miami. The seized
        products--mostly flavored, disposable e-cigarettes as well as some
        packs, kits, and batteries--were valued at more than $7 million and
        included some brands that may appeal to youth, such as Geek Bar. This
        seizure is another example of coordinated enforcement actions across
        federal agencies to curb the distribution and sale of illegal
        e-cigarettes.

Additional Resources:

    --  FDA Newsroom

Media Contact: FDA Office of Media Affairs, 301-796-4540
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-roundup-january-14-2025-302350947.html

SOURCE U.S. Food and Drug Administration